Primary prophylaxis of variceal bleeding in cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 4, 2001, Pages 349-358

  Brett, Bernard T ^a   Hayes, Peter C ^a   Jalan, Rajiv ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Banding; Cirrhosis; HVPG; Keywords; Nitrates; Primary prophylaxis; Propranolol; Variceal haemorrhage; Varices

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ESOPHAGUS VARICES BLEEDING; HEPATIC VEIN; HUMAN; LIGATION; LIVER CIRRHOSIS; LIVER DISEASE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; VENOUS PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; HYPERTENSION, PORTAL; LIFE STYLE; LIGATION; LIVER CIRRHOSIS; RISK ASSESSMENT; RISK FACTORS; SCLEROTHERAPY;

EID: 0035052256     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200104000-00008     Document Type: Review

References (94)

1. Graham DY, Smith JL. The course of patients after variceal haemorrhage. Gastroenterology 1981; 80: 800 -809.
2. Saunders JB, Walters JRF, Davies P, Paton A. A 20-year prospective study of cirrhosis. Br Med J 1981; 282: 263 -266.
3. D'Amico G, Morabito A, Pagliaro L, Marubini A, Liver Study Group of V Cervello Hospital. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468 -475.
4. Stanley AJ, Hayes PC. Portal hypertension and variceal haemorrhage. Lancet 1997; 350: 1235 -1239.
5. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332 -354.
6. Cales P, Pascal JP. Natural history of esophageal varices in cirrhosis (from origin to rupture). Gastroenterologie Clinique et Biologique 1990; 12: 245 -254.
7. Christensen E, Krintel JJ, Hansen M, Johansen JK, Juhl E. Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Scand J Gastroenterol 1989; 24: 999 -1006.
8. Conn HO, Lebrec D, Terblanche J. The treatment of oesophageal varices: a debate and a discussion. J Intern Med 1997; 241: 103 -108.
9. Pugh RNH, Murray Lyons IM, Dawson JL, Pietronni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646 -649.
10. Balanzo J, Villanueva C, Espinos J. et al. Predictive value of the endoscopic signs in variceal bleeding. J Hepatol 1991; 13 (suppl 2): S93. S93.
11. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213 -218.
12. Cales P, Quinton A, Lamouliatte H, Paccalin J, Dabadie H, Tournut R. et al. Facteurs predictifs de la premiere hemorragie digestive et de la mortalite chez les malades cirrhotiques avec varices oesophagiennes. (Predictive factors for the first bleeding event and death in cirrhotic patients with oesophageal varices.) Gastroenterologie Clinique et Biologique 1989; 13: 54 -59.
13. Garden OJ, Motyl H, Gilmour WH, Utley RJ, Carter DC. Prediction of outcome following acute variceal haemorrhage. Br J Surg 1985; 72: 91 -95.
14. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139 -1144.
15. North Italian Endoscopic Club (NIEC) for the study and treatment of esophageal varices. Prediction of first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319: 983 -989.
16. Palmer ED, Brick IB. Correlation between severity of esophageal varices in portal cirrhosis and their propensity toward hemorrhage. Gastroenterology 1956; 30: 85 -90.
17. Prada A, Bortoli A, Minoli G, Carnovali M, Colombo E, Sangiovanni A. Prediction of oesophageal variceal bleeding: evaluation of the beppu and North Italian Endoscopic Club scores by an independent group. Eur J Gastroenterol Hepatol 1994; 6: 1009 -1013.
18. Japanese Research Society for Portal Hypertension. The general rules for recording endoscopic findings of oesophageal varices. Jpn J Surg 1980; 10: 34 -37.
19. Sarin SK, Sundaram KR, Ahuja RK. Predictors of variceal bleeding: an analysis of clinical, endoscopic, and haemodynamic variables, with special reference to intravariceal pressure. Gut 1989; 30: 1757 -1764.
20. Conn HO. Ammonia tolerance in the diagnosis of oesophageal varices. A comparison of endoscopic, radiologic and biochemical techniques. J Lab Clin Med 1967; 70: 442 -451.
21. Westaby D, MacDougall BRD, Malia WM, Theodossi A, William R. A prospective randomised study of two sclerotherapy techniques for oesophageal varices. Hepatology 1983; 3: 681 -684.
22. Colombo E, Casiraghi MA, Minoli G, Prada A, Terruzzi V, Bortoli A. et al. First bleeding episode from oesophageal varices in cirrhotic patients: a prospective study of endoscopic predictive factors. Ital J Gastroenterol 1995; 27: 345 -348.
23. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding Hepatology 1985; 5: 419 -424.
24. Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G. et al. A prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992; 102: 973 -979.
25. Escorsell A, Bordas JM, Castaneda B, Llach J, Garcia-Pagan JC, Rodes J. et al. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 2000; 31: 1061 -1067.
26. Deplano A, Migaleddu V, Pischedda A, Garrucciu G, Gregu G, Multinu C. et al. Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection. Dig Dis Sci 1999; 44: 155 -162.
27. Conn HO, Lindenmuth WW, May CJ, Ramsby GR. Prophylactic portacaval anastomosis. A tale of two studies. Medicine 1972; 51: 27 -40.
28. Inokuchi K, Sugimachi K, Sato T, Sato H, Isono K, Okuda K. et al. Improved survival after prophylactic portal nondecompression surgery for esophageal varices: a randomized clinical trial. Hepatology 1990; 12: 1 -6.
29. Jackson FC, Perrin EB, Smith AG, Dagradi AE, Nadal HM. A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg 1968; 115: 22 -42.
30. Resnick RH, Chalmers TC, Ishihara AM, Garceau J, Callow AD, Schimmel EM. et al. A controlled trial of the prophylactic portacaval shunt. A final report. Ann Intern Med 1969; 70: 675 -688.
31. Rueff B, Prandi D, Sicot J, Degos JD, Sicot C, Maillard JN. et al. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet 1976; ii: 655 -659.
32. Conn HO, Lindenmuth WW, May CJ, Ramsby GR. Prophylactic portacaval anastomosis in cirrhotic patients with esophageal varices. N Engl J Med 1965; 272: 1255 -1263.
33. Baker LA, Smith C, Lieberman G. The natural history of esophageal varices. Am J Med 1959; 26: 228 -237.
34. Dagradi A. The natural history of oesophageal varices in patients with alcoholic liver disease. Am J Gastroenterol 1972; 57: 520 -540.
35. Czaja AJ, Wolf AM, Summerskill WH. Development and early prognosis of esophageal varices in severe chronic active liver disease (CALD) treated with prednisolone. Gastroenterology 1979; 77: 629 -633.
36. Garcia-Pagan JC, Santos C, Barbera JA, Luca A, Roca J, Rodriguez-Roisin R. et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 1996; 111: 1300 -1306.
37. 1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology 1999; 30: 79 -83.
38. Hayes PC, Davis JM, Lewis JA, Bouchier IAD. Meta-analysis of the value of propranolol in the prevention of variceal haemorrhage. Lancet 1990; 336: 153 -156.
39. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L. et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 1991; 324: 1532 -1538.
40. Andreani T, Poupon RE, Balkau BJ, Trinchet JC, Grange JD, Peigney N. et al. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology 1990; 12: 1413 -1419.
41. Colman J, Jones P, Finch C, Dundley F. Propranolol in the prevention of variceal hemorrhage in alcoholic cirrhotic patients [Abstract]. Hepatology 1990; 12: 851. 851.
42. Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodes J, Wright SC. et al. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: a multicenter, randomized controlled clinical trial. Hepatology 1991; 13: 902 -912.
43. Ideo G, Bellati G, Fesce E, Grimoldi D. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology 1988; 8: 6 -9.
44. Italian Multicenter Project for Propranolol in Prevention of Bleeding. Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial. J Hepatol 1989; 9: 75 -83.
45. Lebrec D, Poynard T, Capron JP, Hillon P, Geoffroy P, Roulot D. et al. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. J Hepatol 1988; 7: 118 -125.
46. Pascal JP, Cales P, and Multicentre Study Group. Propranolol in the prevention of first upper gastrointestinal tract haemorrhage in patients with cirrhosis of the liver and oesophageal varices. N Engl J Med 1987; 317: 856 -861.
47. Strauss E, de Sa MFG, Albano A, Lacet CMC, Leite MO, Maffei RA Jr. A randomised controlled trial for the prevention of the first upper gastrointestinal bleeding due to portal hypertension in cirrhosis: sclerotherapy or propranolol versus control groups. Hepatology 1988; 8: 1395. 1395.
48. The PROVA Study Group. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients. A randomised multicenter trial. Hepatology 1991; 14: 1016 -1024.
49. Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ. Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 1997; 112: 473 -482.
50. Luca A, Garcia-Pagan JC, Feu F, Lopez-Talavera JC, Fernandez M, Bru C. et al. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis. J Hepatol 1995; 21: 83 -88.
51. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A. et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056 -1059.
52. Dawson J, Gertsch P, Mosimann F, West R, Elias E. Endoscopic variceal pressure measurements: response to isosorbide dinitrate. Gut 1985; 26: 843 -847.
53. Navasa M, Chesta J, Bosch J, Rodes J. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects upon splanchnic and systemic haemodynamics and liver function. Gastroenterology 1989; 96: 1110 -1118.
54. Angelico M, Carli L, Piat C, Gentile S, Rinaldi V, Bologna E. et al. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 1993; 104: 1460 -1465.
55. Angelico M, Carli Z, Piat C, Gentile S, Capocaccia L. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 2000; 113: 1632 -1639.
56. Merkel C, Marin R, Enzo E, Donada C, Cavallarin G, Torboli P. et al. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale. N Engl J Med 1996; 334: 1624 -1629.
57. Merkel C, Marin R, Sacerdoti D, Donada C, Cavallarin G, Torboli P. et al. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000; 31: 324 -329.
58. Patch D, Goulis J, Gerunda G, Merkel C, Greenslade L, Burroughs AK. A randomised controlled trial comparing wedge pressure guided medical therapy against variceal banding in the secondary prevention of variceal haemorrhage. J Hepatol 2000; 32 (suppl 2): 35. 35.
59. Fardy JM, Laupacis A. A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am J Gastroenterol 1994; 89: 1938 -1947.
60. Andreani T, Poupon RE, Balkau BJ, Trinchet JC, Grange JD, Peigney N. et al. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology 1990; 12: 1413 -1419.
61. De Franchis R, Primignani M, Arcidiacono PG, Rizzi PM, Vitagliano P, Vazzoler MC. et al. Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria: a multicenter randomized controlled trial. Gastroenterology 1991; 101: 1087 -1093.
62. Fleig WE, Stange EF, Wordehoff D. et al. Prophylactic versus therapeutic sclerotherapy in cirrhotic patients with large esophageal varices and no previous hemorrhage: a randomized clinical trial. Hepatology 1988; 8: 1242. 1242.
63. Gregory PB. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. Ann Int Med 1991; 115: 73. 73.
64. Kobe E, Zipprich B, Schentke KU, Nilius R. Prophylactic endoscopic sclerotherapy of esophageal varices - a prospective randomized trial. Endoscopy 1990; 22: 245 -248.
65. Koch H, Henning H, Grimm H, Soehendra N. Prophylactic sclerosing of esophageal varices - results of a prospective controlled study. Endoscopy 1986; 18: 40 -43.
66. Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices: a prospective randomized trial. Endoscopy 1982; 14: 4 -5.
67. Piai G, Cipolletta L, Claar M, Marone G, Bianco MA, Forte G. et al. Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology 1988; 8: 1495 -1500.
68. Potzi R, Bauer P, Reichel W, Kerstan E, Renner F, Gangl A. Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna. Gut 1989; 30: 873 -879.
69. The PROVA Study Group. Prophylaxis of first hemorrhage from patients. A randomised multicenter trial. Hepatology 1991; 14: 1016 -1024.
70. Quer JC, Boix J, Planas R, Dominguez M, Abad-Lacruz A, Humbert P, et al. Prophylactic sclerosis of esophageal varices. Results of a controlled prospective study. Med Clin (Barcelona) 1991; 96:241-244 (in Spanish).
71. Russo A, Giannone G, Magnano A, Passanisi G, Longo C. Prophylactic sclerotherapy in nonalcoholic liver cirrhosis: preliminary results of a prospective controlled randomized trial. World J Surg 1989; 13: 149 -153.
72. Saggioro A, Pallini P, Vitalba A, Bortoluzzi F, Chiozzini G, Di Gilio A. et al. Complications of the endoscopic sclerotherapy of oesophageal varices: comparison between different techniques. Policlinico - Sezione Chirurgica 1987; 94: 461 -464.
73. Santangelo WC, Dueno MI, Estes BL, Krejs GJ. Prophylactic sclerotherapy of large esophageal varices. N Engl J Med 1988; 318: 814 -818.
74. Sauerbruch T, Wotzka R, Kopcke W, Harlin M, Heldwein W, Bayerdorfer E. et al. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients wih cirrhosis. N Engl J Med 1988; 319: 8 -15.
75. Snady H, Feinman L, Lieber CS. Evaluation of propranolol and sclerotherapy, alone and in combination, for the prophylactic treatment of esophageal varices. Am J Gastroenterol 1988; 83: 1065. 1065.
76. Triger DR, Smart HL, Hosking SW, Johnson AG. Prophylactic sclerotherapy for esophageal varices: long-term results of a single-center trial. Hepatology 1991; 13: 117 -123.
77. Witzel L, Wolbergs E, Merki H. Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Lancet 1985; i: 773 -775.
78. Wordehoff D, Spech HJ. Prophylaktische Osophagusvarizensklerosierung: Ergebnisse einer prospektiven, randomisierten Langzeitstudie uber 7 Jahre. (Prophylactic sclerotherapy of oesophageal varices: results of a prospective, randomized long-term trial over seven years.) Deutsche Medizinische Wochenschrift 1987; 112: 947 -951.
79. Heresbach D, Jacquelinet C, Nouel O, Chaperon J, Bretagne JF, Gosselin M. Sclerotherapy versus ligation in hemorrhage caused by rupture of esophageal varices. Direct meta-analysis of randomized trials. Gastroenterol Clin Biol 1995; 19: 914 -920.
80. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for oesophageal bleeding. A meta-analysis. Ann Intern Med 1995; 123: 280 -287.
81. Lay CS, Tsai YT, Teg CY, Shyu WS, Guo WS, Wu KL, Lo KJ. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997; 25: 1346 -1350.
82. Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI, Chiang HT. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. J Hepatol 1999; 31: 451 -456.
83. Omar MM, Attia M, Mostafa I. Prophylactic band ligation of large oesophageal varices. J Hepatol 2000; 32 (suppl 2): 73. 73.
84. Sarin SK, Guptan RKC, Jain AK, Sundaram KR. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol 1996; 8: 337 -342.
85. Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR. et al. Primary prophylaxis of variceal haemorrhage: a randomised controlled trial comparing band ligation, propranolol and isosorbide mononitrate. Hepatology 1999; 30: 318A. 318A.
86. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999; 340: 988 -993.
87. Song IH, Shin JW, Kim IH, Choi J, Lim LY, Kim JW. et al. A prospective randomised trial between prophylactic endoscopic variceal ligation and propranolol administration for prevention of first bleeding in cirrhotic patients with high-risk oesophageal varices. J Hepatol 2000; 32 (suppl 2): 41. 41.
88. Bouchier IAD. Management of oesophageal varices. Eur J Gastroenterol Hepatol 1990; 2: 325 -345.
89. Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G. et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology 1997; 26: 34 -39.
90. Schneider AW, Kalk JF, Klein CP. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 1999; 29: 334 -339.
91. Helmy A, Jalan R, Newby DE, Hayes PC, Webb DJ. Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology 2000; 118: 565 -572.
92. Lahoti S, Catalano MF, Alcocer E, Hogan WJ, Geenen JE. Obliteration of esophageal varices using EUS-guided sclerotherapy with color Doppler. Gastrointest Endosc 2000; 51: 331 -333.
93. Argonz J, Kravetz D, Suarez A, Romero G, Bildozola M, Passamonti M. et al. Variceal band ligation and variceal band ligation plus sclerotherapy in the prevention of recurrent variceal bleeding in cirrhotic patients: a randomized, prospective and controlled trial. Gastrointest Endosc 2000; 51: 157 -163.
94. Hepworth CC, Burnham WR, Swain CP. Development and application of endoloops for the treatment of bleeding esophageal varices. Gastrointest Endosc 1999; 50: 677 -684.